DVP/ FPLC system
Forecast overview
- Subagency
- FDA
- NAICS
- 334516
- Program office
- CBER ACQUISITION
The Laboratory of Immunoregulation (OVRR/DVP) requires a Fast Protein Liquid Chromatography (FPLC) system for purifying peptides and proteins for a project studying the SARS-CoV-2 spike protein structure and function and how this relates to neutralization of the SARS-CoV-2 virus by antibodies generated by vaccines and infections or neutralization by fusion inhibitors such as peptides. PO# 75F40124P00179
Related federal terms
- NAICS — North American Industry Classification System
Acquisition timeline
- Last verified on RFPCapture
- 2026-08-31
- Estimated solicitation
- 5/2026 (agency estimate)
- Estimated award
- 7/2026 (agency estimate)
- Expected period of performance end
- 7/2026 (agency estimate)
Why watch this
- This forecast is tied to an agency with active procurement in this NAICS.
- Recent awards exist in this market.
- Recompete context: Related award history found; treat as related public awards unless SAM.gov confirms a recompete.
Market context
- NAICS market
- NAICS 334516
- Recent comparable awards
- 8 from public USAspending records
- Reported awardee
- QUIDEL CORP
- Agency spending trend
- $238.6M · Declining
Action links
Track this forecast in CaptureIQ
Source
- Source
- HHS SBCX Forecast Export
- Source file
- Forecast.csv
- Official source
- Agency forecast source
- Last verified
- 2026-08-31